← back to search

Susan C. Morpeth

Middlemore Hospital · NZ
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include COVID-19 Clinical Research Studies, Pneumonia and Respiratory Infections, Respiratory viral infections research, and SARS-CoV-2 and COVID-19 Research.
h-index
47
citations
9,535
works
154
NIH funding
primary concept
Medicine
email

Recent publications

Patient-reported Perceptions, Experiences, and Preferences Around Intravenous and Oral Antibiotics for the Treatment of <i>Staphylococcus aureus</i> Bacteremia: A Descriptive Qualitative Study
Clinical Infectious Diseases 2025cited by 3position: middledoi
From random care to randomized clinical trials of patients with invasive streptococcal infections—research prioritisation and areas of equipoise
CMI Communications 2025cited by 1position: contributordoi
Does Adjunctive Clindamycin Have a Role in <i>Staphylococcus aureus</i> Bacteremia? A Protocol for the Adjunctive Treatment Domain of the <i>Staphylococcus aureus</i> Network Adaptive Platform (SNAP) Randomized Controlled Trial
Clinical Infectious Diseases 2024cited by 13position: middledoi
Early Oral Antibiotic Switch in <i>Staphylococcus aureus</i> Bacteraemia: The <i>Staphylococcus aureus</i> Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol
Clinical Infectious Diseases 2023cited by 19position: middledoi
A Randomized Trial of Nafamostat for Covid-19
NEJM Evidence 2023cited by 13position: firstdoi
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials
2023cited by 0position: contributordoi
The<i>Staphylococcus aureus</i>Network Adaptive Platform Trial Protocol: New Tools for an Old Foe
Clinical Infectious Diseases 2022cited by 95position: middledoi
Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19
NEJM Evidence 2022cited by 26position: middledoi
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review.
2022cited by 20position: contributordoi
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Nature Communications 2021cited by 292position: middledoi
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Intensive Care Medicine 2021cited by 99position: middledoi
Epidemiology of the Rhinovirus (RV) in African and Southeast Asian Children: A Case-Control Pneumonia Etiology Study
Viruses 2021cited by 20position: middledoi
The Etiology of Pneumonia in HIV-uninfected Children in Kilifi, Kenya
The Pediatric Infectious Disease Journal 2021cited by 10position: middledoi
Upper Respiratory Tract Co-detection of Human Endemic Coronaviruses and High-density Pneumococcus Associated With Increased Severity Among HIV-Uninfected Children Under 5 Years Old in the PERCH Study
The Pediatric Infectious Disease Journal 2021cited by 8position: middledoi
The Etiology of Pneumonia From Analysis of Lung Aspirate and Pleural Fluid Samples: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study
Clinical Infectious Diseases 2020cited by 23position: middledoi
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency
BMC Medicine 2020cited by 7position: middledoi
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
The Lancet 2019cited by 168position: middledoi
Carriage and Acquisition of Extended-spectrum β-Lactamase–producing Enterobacterales Among Neonates Admitted to Hospital in Kilifi, Kenya
Clinical Infectious Diseases 2018cited by 46position: lastdoi
Impact of viral upper respiratory tract infection on the concentration of nasopharyngeal pneumococcal carriage among Kenyan children
Scientific Reports 2018cited by 34position: firstdoi
Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged &lt;5 Years in the PERCH Study
Clinical Infectious Diseases 2017cited by 109position: middledoi
Is Higher Viral Load in the Upper Respiratory Tract Associated With Severe Pneumonia? Findings From the PERCH Study
Clinical Infectious Diseases 2017cited by 95position: middledoi
Molecular epidemiology of Klebsiella pneumoniae invasive infections over a decade at Kilifi County Hospital in Kenya
International Journal of Medical Microbiology 2017cited by 88position: lastdoi
Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study
Clinical Infectious Diseases 2017cited by 71position: middledoi
Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia—Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii
Clinical Infectious Diseases 2017cited by 66position: middledoi
Safety of Induced Sputum Collection in Children Hospitalized With Severe or Very Severe Pneumonia
Clinical Infectious Diseases 2017cited by 59position: middledoi
Standardization of Laboratory Methods for the PERCH Study
Clinical Infectious Diseases 2017cited by 53position: middledoi
Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study
Clinical Infectious Diseases 2017cited by 48position: middledoi
Detection of Pneumococcal DNA in Blood by Polymerase Chain Reaction for Diagnosing Pneumococcal Pneumonia in Young Children From Low- and Middle-Income Countries
Clinical Infectious Diseases 2017cited by 41position: firstdoi
The Diagnostic Utility of Induced Sputum Microscopy and Culture in Childhood Pneumonia
Clinical Infectious Diseases 2017cited by 35position: middledoi
Standardization of Clinical Assessment and Sample Collection Across All PERCH Study Sites
Clinical Infectious Diseases 2017cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

J. Anthony G. Scott · Haramaya University14 papers (2014–2021)Neema Mturi · Kenya Medical Research Institute7 papers (2015–2019)Laura L. Hammitt · Johns Hopkins University6 papers (2014–2021)Salim Mwarumba · London School of Hygiene & Tropical Medicine5 papers (2015–2021)Angela Karani · University of London5 papers (2014–2021)Sammy Nyongesa · London School of Hygiene & Tropical Medicine4 papers (2014–2021)Thomas N. Williams · London School of Hygiene & Tropical Medicine4 papers (2014–2019)James A. Berkley · Angkor Hospital for Children4 papers (2015–2018)Steven Y. C. Tong · BGI Group (China)4 papers (2022–2025)Samuel Kariuki · Gifu University3 papers (2015–2017)David R. Murdoch · Christchurch Hospital3 papers (2014–2021)Anna C. Seale · Haramaya University3 papers (2016–2018)Anthony Etyang · London School of Hygiene & Tropical Medicine3 papers (2014–2019) · 3 papers (2014–2019) · 3 papers (2014–2019) · 3 papers (2022–2025) · 3 papers (2022–2025)John Ojal · London School of Hygiene & Tropical Medicine3 papers (2014–2019)Maria Deloria Knoll · University of the Witwatersrand3 papers (2014–2021)Joshua S. Davis · Albany Medical Center Hospital3 papers (2023–2025)